Chemoinformaics analysis of 9,19-cyclolanost-24-en-3-ol, acetate, (3beta)-
| Molecular Weight | 468.766 | nRot | 5 |
| Heavy Atom Molecular Weight | 416.35 | nRig | 24 |
| Exact Molecular Weight | 468.397 | nRing | 5 |
| Solubility: LogS | -7.018 | nHRing | 0 |
| Solubility: LogP | 7.813 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 86 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 89.7172 |
| nHD | 0 | BPOL | 54.7708 |
| QED | 0.298 |
| Synth | 5.398 |
| Natural Product Likeliness | 3.181 |
| NR-PPAR-gamma | 0.259 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.007 |
| Pgp-sub | 0 |
| HIA | 0.013 |
| CACO-2 | -4.948 |
| MDCK | 0.000011 |
| BBB | 0.211 |
| PPB | 1.00079 |
| VDSS | 1.843 |
| FU | 0.0158963 |
| CYP1A2-inh | 0.022 |
| CYP1A2-sub | 0.201 |
| CYP2c19-inh | 0.071 |
| CYP2c19-sub | 0.948 |
| CYP2c9-inh | 0.087 |
| CYP2c9-sub | 0.413 |
| CYP2d6-inh | 0.043 |
| CYP2d6-sub | 0.208 |
| CYP3a4-inh | 0.271 |
| CYP3a4-sub | 0.496 |
| CL | 11.223 |
| T12 | 0.007 |
| hERG | 0.186 |
| Ames | 0.013 |
| ROA | 0.065 |
| SkinSen | 0.223 |
| Carcinogencity | 0.02 |
| EI | 0.074 |
| Respiratory | 0.842 |
| NR-Aromatase | 0.307 |
| Antiviral | No |
| Prediction | 0.542402 |